EUVIMEDEUVIMED entdecken
Crossref

LncRNA FGF13-AS1 predicts delayed fracture healing and promotes osteoporotic fracture healing by regulating miR-128-3p/CBFB-mediated osteogenesis and osteoclast activity

Shanchuan Yao, Jiande Meng, Zhou Qin, Yuanyuan Zhang

Bone · 2026-08 · 209 · 117897

DOI: 10.1016/j.bone.2026.117897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2026-08. Verfasst von Shanchuan Yao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, First People's Hospital of Zunyi City, Guizhou Province (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, …. Hauptthemen laut MEDLINE: MicroRNAs, Osteoclasts, Fracture Healing, Osteogenesis. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Osteoporotic fracture (OPF) disrupts bone homeostasis via resorption-formation imbalance. This study investigates the expression and role of the long non-coding RNA FGF13 antisense RNA 1 (FGF13-AS1) in OPF bone healing. METHODS Recruited 110 patients with osteoporosis (OP) and 138 patients with OPF and 90 healthy people, then divided OPF patients into normal healing (NFH) and delayed healing groups (DFH) after a 4-month follow-up. In vitro, MC3T3-E1 cells undergo osteogenic differentiation while RAW264.7 cells undergo osteoclastogenic differentiation. Serum FGF13-AS1 and miR-128-3p levels were determined by real-time quantitative reverse transcription PCR (RT-qPCR). The receiver operating characteristic (ROC) curve assessed FGF13-AS1's diagnostic value for OP. Logistic regression pinpointed potential risk factors for DFH. Cell counting kit-8 (CCK-8) and flow cytometry assays were used to determine cell proliferation and apoptosis. Alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TRAP) activity were measured via commercial kits. RT-qPCR evaluated expression of osteogenic and osteoclast differentiation markers. RESULTS Serum FGF13-AS1 levels decline significantly in OP patients, particularly in OPF cases. DFH patients have lower levels than NFH patients. Low FGF13-AS1 expression predicts DFH and is a potential risk factor for its onset. MC3T3-E1 cells in osteoblastic differentiation showed marked upregulation of FGF13-AS1 and core-binding factor subunit β (CBFB) and downregulation of miR-128-3p. FGF13-AS1 overexpression enhanced ALP activity, osteogenic marker expression, and cell proliferation, and suppressed apoptosis; miR-128-3p effectively reversed these effects. During osteoclast differentiation, FGF13-AS1 and CBFB decreased, and miR-128-3p increased. Inhibition of FGF13-AS1 elevated TRAP activity and osteoclast differentiation markers. This effect was markedly mitigated by reducing miR-128-3p levels. CONCLUSION Low FGF13-AS1 serves as a marker for delayed fracture healing in osteoporosis. It likely acts via the miR-128-3p/CBFB axis to balance osteogenic differentiation and promote bone formation. Deficiency of FGF13-AS1 may contribute to delayed healing and represents a potential clinical molecular target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOsteoclastsFracture HealingOsteogenesisRNA, Long NoncodingOsteoporotic FracturesHumansFemaleAnimalsMiceMaleCell DifferentiationAgedRAW 264.7 CellsMiddle AgedCell ProliferationApoptosis

Stichwörter der Autor:innen

FGF13-AS1Osteoblastic differentiationOsteoporotic fracturePredictive valuemiR-128-3p

Substanzen

MicroRNAsRNA, Long NoncodingMIRN128 microRNA, human

Autor:innen und Institutionen

  • Department of Emergency, First People's Hospital of Zunyi City, Guizhou Province (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, 563000, China.
  • Department of Orthopedic, Dongguan Eighth People's Hospital, Dongguan, 523320, China.
  • Key Laboratory of Clinical Cohort Research on Bone and Joint Degenerative Diseases of Guangxi, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
  • Department of Hand and Foot Surgery Ward, Zibo Central Hospital, Zibo, 255000, China. Electronic address: zhangyuanyuan8212@163.com.

Zitieren

APA

Yao, S., Meng, J., Qin, Z., & Zhang, Y. (2026). LncRNA FGF13-AS1 predicts delayed fracture healing and promotes osteoporotic fracture healing by regulating miR-128-3p/CBFB-mediated osteogenesis and osteoclast activity. Bone, 209, 117897. https://doi.org/10.1016/j.bone.2026.117897

Vancouver

Yao S, Meng J, Qin Z, Zhang Y. LncRNA FGF13-AS1 predicts delayed fracture healing and promotes osteoporotic fracture healing by regulating miR-128-3p/CBFB-mediated osteogenesis and osteoclast activity. Bone. 2026;209:117897. doi:10.1016/j.bone.2026.117897

BibTeX
@article{Yao2026,
  author = {Yao, Shanchuan and Meng, Jiande and Qin, Zhou and Zhang, Yuanyuan},
  title = {LncRNA FGF13-AS1 predicts delayed fracture healing and promotes osteoporotic fracture healing by regulating miR-128-3p/CBFB-mediated osteogenesis and osteoclast activity},
  journal = {Bone},
  year = {2026},
  volume = {209},
  pages = {117897},
  doi = {10.1016/j.bone.2026.117897}
}
Kostenlos starten →